Clinical Trials Directory

Trials / Unknown

UnknownNCT04076514

The Role of Central Neck Dissection in Stage N0 Papillary Thyroid Carcinoma

Status
Unknown
Phase
Study type
Observational
Enrollment
20 (estimated)
Sponsor
Assiut University · Academic / Other
Sex
All
Age
16 Years
Healthy volunteers
Accepted

Summary

The benefits of prophylactic central neck dissection (pCND) remain controversial in clinically node-negative (cN0) papillary thyroid carcinoma (PTC). This study main goal is to investigate benefits of prophylactic central neck dissection in clinically node-negative papillary thyroid carcinoma.

Detailed description

Papillary thyroid carcinoma (PTC) is the most common type of differentiated thyroid carcinoma. Recurrence rate is still high. The standard management is total thyroidectomy. regional lymph node metastasis is noted in recurrent cases. Some studies stated benefits of central neck dissection in orevention of recurrence and others said there is no benefits. so prophylactic central neck dissection (pCND) remain controversial in clinically node-negative (cN0) papillary thyroid carcinoma (PTC).

Conditions

Interventions

TypeNameDescription
PROCEDUREcentral neck dissectiondissection of central cervical lymph node grope in low grade papillary thyroid cancer

Timeline

Start date
2020-09-01
Primary completion
2020-09-30
Completion
2020-11-01
First posted
2019-09-03
Last updated
2020-07-14

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT04076514. Inclusion in this directory is not an endorsement.

The Role of Central Neck Dissection in Stage N0 Papillary Thyroid Carcinoma (NCT04076514) · Clinical Trials Directory